Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-12+17,500→ 17,500 totalExercise: $68.87Exp: 2030-02-12→ Common Stock (17,500 underlying)
Footnotes (1)
- [F1]The securities awarded on February 12, 2020 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 4,375 shares of common stock shall vest on the one year anniversary of February 12, 2020, with 13,125 shares vesting in 36 equal monthly installments thereafter.